chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccines 11/30/06. 12/01/06 rt arm appeared bruised, 12/02/06 inflamed. Getting flu sx temp 101, chills, HA severe, 12/02/06. Gave her VI antibiotics home on Keflex. 12/03/06 redness moved to elbow, itchy, burning, temp 101, more IV antibiotics at ER . Put on Clindamycin. 12/04/2006 fever 99. Little more redness about level of elbow. 12/05/06 back to ER and kept overnight with more IV antibiotics. Home back on Keflex. Took Clindamycin x 1.5 days Ibuprofen. 12/06/06 Home today, less redness, still itching and burning fever gone, DX cellulitis. Had flu vaccine before, chicken pos vaccine usual reaction, not unusual.  12/8/06 T/C to provider revealed TDaP given in left arm, flu & pneumo in right arm.  2/2/07 Received medical records from hospital which reveal patient experienced right upper arm pain, swelling, warmth & redness at pneumovax site.  Seen in ER on 12/2 for flu like symptoms & stiff neck/HA.  Tx w/IV antibiotics & d/c to home on oral antibiotics.  Returned to ER on 12/3 for spreading cellulitis of right arm, fever & cough w/green sputum since vax.  Received additional IV antibiotics & admit recommended but pt declined, preferred to return to ER daily for checks.  Returned to ER on 12/5 & was admitted overnight this time with right arm cellulitis, failed outpatient treatment.  Improved significantly on IV antibiotics & was d/c home on continued oral antibiotics. FINAL DX: Cellulitis right arm s/p pneumovax.
Dysphonia; COVID-19; This is a spontaneous report based on the information received by Pfizer (MFR Control No. 2021BHV000459(0)). A pharmacist (company representative) reported for a female patient. A female patient of an unspecified age received bnt162b2 BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via unknown route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient experienced covid-19 and dysphonia after taking Pfizer covid-19 Vaccine. Causality as per reporter was not reported for covid-19 and dysphonia. Outcome of the event covid-19 was recovering and outcome of the event dysphonia was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt given injection on 8-14-13, Rt deltoid, IM. Correct placement. Pain in Rt upper arm going to arm pit and shoulder with stomach cramps. Woke up at 5:00 AM now pain up to neck and Rt back. Small amt swelling and feels warm. Pt does not have a fever.
I had a heart attack 13 days following the vaccine. I had tightness across the chest and went to hospital where I had the heart attack. I was airlifted to Medical Center for treatment.
Husband tested positive for COVID-19. Then I started having a slight cough, fever and body aches, took a home COVID-19 test and it was positive. Took advisement from my Dr.
MODERATE ACHES AND PAIN; FATIGUE; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On MAR-2021, the subject experienced moderate aches and pain. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from moderate aches and pain, and fatigue on MAR-2021. This report was non-serious.
Within 1 hour of vaccination, pt noted pain left deltoid and left side of neck. Pt has felt feverish since then with a throbbing "deep bone pain" at left deltoid after left upper arm extension and/or external rotation movements. Pt denies paresthesia, weakness. Pt is afebrile on exam today. Tx: Advil, heat to deltoid, rest muscle. Report if greater or no change in 5-7 days.
Approximately one week after receiving immunes, pt broke out in a red, raised rash on abdomen, back, forehead
This case was reported by a healthcare professional and described the occurrence of diarrhea in a 51-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline). The subject's medical history included gastrointestinal sensitivity, high blood pressure and sulfa allergy. Previous vaccination included the 1st dose of TWINRIX (GlaxoSmithKline) given on an unspecified date. Concurrent medications included Atenolol and PREMARIN. On 19 February 2008 the subject received the 2nd dose of TWINRIX (1ml unknown, right arm). On 19 February 2008, less than one day after vaccination with TWINRIX, the subject experienced diarrhea. On the morning of February 2008, the subject experienced nausea. Later in the day on 20 February 2008, the subject experienced vomiting. The nausea and vomiting resolved at an unspecified time on the same day the symptoms developed. At the time of this report, diarrhea was reported to be improved, but not resolved. The healthcare professional stated that the subject experienced no symptoms following her 1st dose of the TWINRIX vaccine. The healthcare professional considered the events were probably related to vaccination with TWINRIX. Follow-up information was received on 11 March 2008 via a nurse, who reported that the events were improved. The healthcare professional did not consider the events to be serious, and listed rest and time to recover as the only action taken following these events. The nurse stated that the immunization series had not been continued at the time of this report, as the subject is awaiting her physician's opinion as to whether the 3rd dose of the TWINRIX series should be administered.
Patient passed out shortly after vaccination. EMS laid the patient down and gave her a cold pack, water, and snacks. Once she was feeling well enough, the patient was driven home.   Recorded as EMS Incident #.
Fatigue; Fever; Injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), PYREXIA (Fever) and VACCINATION SITE PAIN (Injection site soreness) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included LOSARTAN POTASSIUM for Blood pressure fluctuation.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (Fever) and VACCINATION SITE PAIN (Injection site soreness). On 08-Jan-2021, VACCINATION SITE PAIN (Injection site soreness) had resolved. On 09-Jan-2021, FATIGUE (Fatigue) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Fatigue and fever that subside after taking a fresh air outside. No treatment information was provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
9-10 extreme stiffness and flushing around the ears  9/15 Felt mild fatigue 9/21 Felt extreme fatigue with heaviness in arms and legs, dizziness, nausea, night tremors  10/16 Symptoms of fatigue and heaviness have persisted.
Achy Joints, Elevated Temperature , Insta-Read Thermometer 101.2 Forehead, 102 Armpit
more pain all over the left side of their body; whole left arm hurts; pain in their kidney; pain in their chest; pain under their left arm; left wrist hurts/left elbow hurts; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (more pain all over the left side of their body), PAIN IN EXTREMITY (whole left arm hurts), RENAL PAIN (pain in their kidney), CHEST PAIN (pain in their chest) and VACCINATION SITE PAIN (pain at the injection site) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.     On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 12-Aug-2021, the patient experienced PAIN (more pain all over the left side of their body), PAIN IN EXTREMITY (whole left arm hurts), RENAL PAIN (pain in their kidney), CHEST PAIN (pain in their chest), AXILLARY PAIN (pain under their left arm) and ARTHRALGIA (left wrist hurts/left elbow hurts). At the time of the report, PAIN (more pain all over the left side of their body), PAIN IN EXTREMITY (whole left arm hurts), RENAL PAIN (pain in their kidney), CHEST PAIN (pain in their chest), VACCINATION SITE PAIN (pain at the injection site), AXILLARY PAIN (pain under their left arm) and ARTHRALGIA (left wrist hurts/left elbow hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated they did not take any medications regularly. No Treatment information was provided. After six days of vaccine administration, patient developed more pain all over the left side of their body, their whole left arm hurts, left elbow, left wrist, they have pain under their left arm, in their kidney and their chest.
Patient while at home developed 104 temp and seziure. Presented to hospital for treatment.
Resident administered expired Moderna vaccine, expired on 10/13/2021. No ASE noted.
After got vaccination, the patient developed incurable eczema; This spontaneous report has been received from a consumer referring to her daughter, a female of unknown age. Information about the patient's past drug and medical history, as well as her concomitant therapies and allergies were not reported.  On an unknown date, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection (concentration, dosage, anatomical location, administration route, lot number, and expiration date were not reported) for prophylaxis. Subsequently, the patient developed incurable eczema. The outcome of the event was unknown. Therefore, the patient was not recovered from the event at the reporting time.   It was unknown if the patient sought medical attention, or if she performed any laboratories or studies.  The causality assessment between Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and the occurred event was not reported.  This is one of two cases from the same reporter.; Sender's Comments:  US-009507513-2001USA000651:
8/12/2021- symptoms began as stated below 8/16/2021- ED arrival with increased SOB, cough, headache, fever, chills, nausea- "Covid outbreak at work/church" Covid swab in ED which was positive J&J vaccine on 5/22/2021per patient
Redness, swelling, warm to touch. Cellulitis to right thigh. Keflex 200 mg QID for 7 days.
Morbilliform rash on all extremities, trunk, neck and few on face.  Palms and soles spared. No fever. Mild itching.
I tested positive for COVID-19 on 12/29/2022. I had a mild cough with production, and a little bit of a runny nose and some fatigue. I took Paxlovid starting 12/30/2022. My doctor prescribed that for me and I had the worst taste in my mouth. In general, my COVID-19 infection was very mild. I didn't really think I had it. My wife had the infection too that was more substantial than mine. We took the COVID-19 tests at home to confirm. In general, I've always had very strong reactions to the vaccines, so I believe my immune system was ready to go when the time came. About a month after my COVID-19 infection, I had an acute pancreatitis attack. On 02/04/2022, I had acute pancreatic attack with thrushing abdominal pain and back pain. Part of that, I basically had a lack of appetite that went back to my COVID-19 infection. My appetite reduced and my stool was loose for that period of time. I was hospitalized for 3 days and they treated me with antibiotics and bland diet. The bland diet is still ongoing. I've recovered from the COVID-19 infection, but I'm still recovering from the pancreas health event.
Dizziness and lightheadedness that continued through several days. Bought blood pressure monitor and the blood pressure is through the roof. My normal blood pressure is 110/68, this time it was 157/87.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. The reporter said that her arm was barely sore (not enough to complain) at the injection site and not red at all (after the first shot of SHINGRIX, refer case US2018151874) and that was not different than after getting a flu shot. This case has been linked cases US2018GSK153694 (2nd dose of SHINGRIX) and US2018GSK152142 for different patient, reported by same reporter.
Discomfort at the injection site; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Discomfort at the injection site) and FATIGUE (Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOMFORT (Discomfort at the injection site) and FATIGUE (Tiredness). At the time of the report, VACCINATION SITE DISCOMFORT (Discomfort at the injection site) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
When she got ready to go to bed she started with the chills. She had a slight fever before that and the next morning her whole body ached. She had diarrhea and getting headaches off and on.
Recent blood test showed a Negative reading for Antibodies Advised by Doctor to get another Vaccination
Pt appeared to have quite a bit of bleeding at injection site and down arm (left) also itching at site and on neck area.
Approximately 2 weeks after receiving varicella virus vaccine live the pt presented with lesions and was diagnosed with chickenpox.
T 101.5 (orally) and vomiting 24 hrs after receiving immunization gastroenteritis vs reaction to immunization.
Child woke mother at 150 am 5/12/2011 "making a noise". Temp up baby felt hot. Started to shake "very hot" mother started to sponge baby on the floor and was wiping her down when she had a jerking all over. Temp 103 at local ER.
IMMEDIATELY FAINTED, HEADACHE, CRYING, LOST CONSCIOUSNESS; DIDN'T KNOW IF SHE WAS ALIVE OR DREAMING AT THE INJECTION OF 3 THREE VACCINES ON JANUARY 10, 2023 AT AN UNKNOWN TIME. ALSO HIT HER HEAD ON A MIRROR AT FAINTING. PALOR.
Patient was admitted due to having a syncopal or near syncopal episode while dry heaving. She was found to have a probable gastric outlet obstruction and an NG tube was placed initially. She is being followed by general surgery and GI, underwent EGD which showed duodenitis. Pt's diet has progressed to full liquid. She remains in the hospital at this time. Per the EUA, hospitalizations are to be reported irrespective of attribution to the vaccine
Started to get a red swelled up spot roughly 1.5 inches diameter around injection site about 24HRS after moderna booster, skin feels hotter than surrounding unaffected skin, very sore to touch  Another 24HRS later the spot has gone to about tennis ball size (circumference, not in reference to swelling/protrusion), still sore and hot feeling.  12HRS later, 60HRS post injection, roughly same size, but started to get itchy and redness/swelling area has now gotten textured, like goosebumps but only in the red area. Still very sore and warm to the touch.
Felt sensation of tightness in chest or fast heartbeat; Felt sensation of tightness in chest or fast heartbeat; Shaking hands; Tingling forearms; Jerking movement in hands; Looked like a parkinson's patient; Brief tingling in lips; Sharp pain in mid back; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: ER8731), via an unspecified route of administration, administered in arm right on 19Apr2021 at 12:45 (at an age of 49-years-old) as dose 1, single for covid-19 immunisation at Pharmacy or Drug Store. Medical history included asthma, sulphonamide allergy and morphine allergy. The patient's concomitant medications were not reported. Patient not diagnosed with covid-19 prior to vaccination. Patient was not received any other vaccine prior four weeks of vaccination and patient did not receive any medication prior two weeks of vaccination. On 19Apr2021, about 2 minutes after shot the patient experienced shaking hands, tingling forearms, jerking movement in hands looked like a Parkinson's patient. Brief tingling in lips, felt sensation of tightness in chest or fast heartbeat like having had lots of coffee. Sharp pain in mid back this was all very dramatic and fast but disappeared fully within an hour No problems at all overnight or the next day. Since vaccination patient not tested for covid-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events was recovered on unspecified date in 2021.  Follow-up attempts are needed. Further information is requested.
This spontaneous report was received from a medical assistant referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug and allergy history were not reported. On unspecified dates, the patients were vaccinated with improperly stored injections of two different lot # of GARDASIL 9, lot # M031557, expiration date 07-APR-2019 and/or lot # M037770 expiration date 01-JUN-2019 (dose and route of administration were not provided) for prophylaxis. On an unspecified date, the GARDASIL 9 were exposed to temperature ranges between 32° Fahrenheit (F) to 35°F during a time frame of 4 hours. There was not previous temperature excursion, the temperature excursion was not called by a data logger. Adverse effects were not reported. This is one of two reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1706USA004563.
This spontaneous report was received from a Registered Nurse concerning multiple patients of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On unspecified dates, the patients were vaccinated with an improperly stored dose of ROTATEQ lot# R002806; expiration date 29-SEP-2019 orally (dose and route of administration were not provided) for prophylaxis, which had a temperature excursion of 21.7°C for 8 hours and 30 minutes with no previous temperature excursions. Digital data logger was involved in recording the temperature excursion. No adverse effects were reported.
Injection given high on the deltoid. Employee immediately had pain which was localized in the right shoulder and radiated up her right neck and occipital area.
Vaccines administered 10:00 -11:00 am 11/2/04, fever discovered around 6PM upon parents picking up from daycare. Fever continued overnight, max 101.3 (ax). Also increased edema, warmth without erythema at site of Prevnar compared to other vaccine administration site and mildly tender.
Feeling weak; Lightheadedness; Queasy; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (Feeling weak), DIZZINESS (Lightheadedness) and NAUSEA (Queasy) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Feeling weak), DIZZINESS (Lightheadedness) and NAUSEA (Queasy). At the time of the report, ASTHENIA (Feeling weak), DIZZINESS (Lightheadedness) and NAUSEA (Queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided.  Treatment information was not provided.